168 related articles for article (PubMed ID: 29434961)
21. Pyrrolidine dithiocarbamate sensitizes U251 brain glioma cells to temozolomide via downregulation of
Tang JH; Huang GH; Mou KJ; Zhang EE; Li N; Du L; Zhu XP; Chen L; Yang H; Zhang KB; Lv SQ
Oncol Lett; 2017 Nov; 14(5):5135-5144. PubMed ID: 29098021
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells.
Harder BG; Peng S; Sereduk CP; Sodoma AM; Kitange GJ; Loftus JC; Sarkaria JN; Tran NL
Mol Med; 2019 Nov; 25(1):49. PubMed ID: 31726966
[TBL] [Abstract][Full Text] [Related]
23. Chemoresistance to temozolomide in human glioma cell line U251 is associated with increased activity of O6-methylguanine-DNA methyltransferase and can be overcome by metronomic temozolomide regimen.
Pan Q; Yang XJ; Wang HM; Dong XT; Wang W; Li Y; Li JM
Cell Biochem Biophys; 2012 Jan; 62(1):185-91. PubMed ID: 21892781
[TBL] [Abstract][Full Text] [Related]
24. Borneol promotes autophagic degradation of HIF-1α and enhances chemotherapy sensitivity in malignant glioma.
Lin L; Luo J; Wang Z; Cai X
PeerJ; 2024; 12():e16691. PubMed ID: 38188151
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of NURP1 in temozolomide resistance in hypoxia-treated glioma cells via the KDM3A/TFEB axis.
Li T; Fu X; Wang J; Shang W; Wang X; Zhang L; Li J
Oncol Res; 2023; 31(3):345-359. PubMed ID: 37305393
[TBL] [Abstract][Full Text] [Related]
26. Pre-treatment or Post-treatment of Human Glioma Cells With BIX01294, the Inhibitor of Histone Methyltransferase G9a, Sensitizes Cells to Temozolomide.
Ciechomska IA; Marciniak MP; Jackl J; Kaminska B
Front Pharmacol; 2018; 9():1271. PubMed ID: 30450051
[TBL] [Abstract][Full Text] [Related]
27. LRIG1 dictates the chemo-sensitivity of temozolomide (TMZ) in U251 glioblastoma cells via down-regulation of EGFR/topoisomerase-2/Bcl-2.
Qi XC; Xie DJ; Yan QF; Wang YR; Zhu YX; Qian C; Yang SX
Biochem Biophys Res Commun; 2013 Aug; 437(4):565-72. PubMed ID: 23850692
[TBL] [Abstract][Full Text] [Related]
28. Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy.
Su J; Xu Y; Zhou L; Yu HM; Kang JS; Liu N; Quan CS; Sun LK
Anat Rec (Hoboken); 2013 Apr; 296(4):595-603. PubMed ID: 23408563
[TBL] [Abstract][Full Text] [Related]
29. Late autophagy inhibitor chloroquine improves efficacy of the histone deacetylase inhibitor SAHA and temozolomide in gliomas.
Gonçalves RM; Agnes JP; Delgobo M; de Souza PO; Thomé MP; Heimfarth L; Lenz G; Moreira JCF; Zanotto-Filho A
Biochem Pharmacol; 2019 May; 163():440-450. PubMed ID: 30878553
[TBL] [Abstract][Full Text] [Related]
30. Isocucurbitacin B inhibits glioma growth through PI3K/AKT pathways and increases glioma sensitivity to TMZ by inhibiting hsa-mir-1286a.
Han M; An J; Li S; Fan H; Wang L; Du Q; Du J; Yang Y; Song Y; Peng F
Cancer Drug Resist; 2024; 7():16. PubMed ID: 38835342
[No Abstract] [Full Text] [Related]
31. Down-Regulation of AQP4 Expression via p38 MAPK Signaling in Temozolomide-Induced Glioma Cells Growth Inhibition and Invasion Impairment.
Chen Y; Gao F; Jiang R; Liu H; Hou J; Yi Y; Kang L; Liu X; Li Y; Yang M
J Cell Biochem; 2017 Dec; 118(12):4905-4913. PubMed ID: 28569417
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
[TBL] [Abstract][Full Text] [Related]
33. MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy.
Huang T; Wan X; Alvarez AA; James CD; Song X; Yang Y; Sastry N; Nakano I; Sulman EP; Hu B; Cheng SY
Autophagy; 2019 Jun; 15(6):1100-1111. PubMed ID: 30654687
[TBL] [Abstract][Full Text] [Related]
34. Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells.
Chio CC; Chen KY; Chang CK; Chuang JY; Liu CC; Liu SH; Chen RM
BMC Cancer; 2018 Apr; 18(1):379. PubMed ID: 29614990
[TBL] [Abstract][Full Text] [Related]
35. The Effect of Chemoradiotherapy with SRC Tyrosine Kinase Inhibitor, PP2 and Temozolomide on Malignant Glioma Cells In Vitro and In Vivo.
Eom KY; Cho BJ; Choi EJ; Kim JH; Chie EK; Wu HG; Kim IH; Paek SH; Kim JS; Kim IA
Cancer Res Treat; 2016 Apr; 48(2):687-97. PubMed ID: 26044161
[TBL] [Abstract][Full Text] [Related]
36. Guanosine promotes cytotoxicity via adenosine receptors and induces apoptosis in temozolomide-treated A172 glioma cells.
Oliveira KA; Dal-Cim TA; Lopes FG; Nedel CB; Tasca CI
Purinergic Signal; 2017 Sep; 13(3):305-318. PubMed ID: 28536931
[TBL] [Abstract][Full Text] [Related]
37. ROS-dependent activation of autophagy is a critical mechanism for the induction of anti-glioma effect of sanguinarine.
Pallichankandy S; Rahman A; Thayyullathil F; Galadari S
Free Radic Biol Med; 2015 Dec; 89():708-20. PubMed ID: 26472194
[TBL] [Abstract][Full Text] [Related]
38. Single-cell analysis challenges the connection between autophagy and senescence induced by DNA damage.
Filippi-Chiela EC; Bueno e Silva MM; Thomé MP; Lenz G
Autophagy; 2015; 11(7):1099-113. PubMed ID: 25701485
[TBL] [Abstract][Full Text] [Related]
39. Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors.
Golden EB; Cho HY; Hofman FM; Louie SG; Schönthal AH; Chen TC
Neurosurg Focus; 2015 Mar; 38(3):E12. PubMed ID: 25727221
[TBL] [Abstract][Full Text] [Related]
40. MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2.
Zhang X; Yu J; Zhao C; Ren H; Yuan Z; Zhang B; Zhuang J; Wang J; Feng B
Biomed Pharmacother; 2019 Jan; 109():2192-2202. PubMed ID: 30551476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
